Olanzapine Tablet, Film Coated
Product Images NDC 70518-3568

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 70518-3568). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Olanzapineusp)

Chemical structure of olanzapine, showing its heterocyclic ring system including a thiazepine ring fused to a benzene ring, and a methylated piperazine moiety.*

FDA Label Image

Remedy_label (Remedy Label)

Label for Olanzapine 2.5 mg film coated tablets by RemedyRepack Inc. The package contains 30 tablets for oral use. The label includes storage instructions to protect from light and moisture, and mentions repackaging by RemedyRepack Inc., Indiana. Manufacturer is Apotex Inc., Toronto, Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.